Next Article in Journal
Preclinical Safety Profile of an Oral Naringenin/Hesperidin Dosage Form by In Vivo Toxicological Tests
Previous Article in Journal
Binding of GS-461203 and Its Halogen Derivatives to HCV Genotype 2a RNA Polymerase Drug Resistance Mutants
 
 
Article

Article Versions Notes

Sci. Pharm. 2022, 90(2), 27; https://doi.org/10.3390/scipharm90020027
Action Date Notes Link
article xml file uploaded 26 April 2022 07:38 CEST Original file -
article xml uploaded. 26 April 2022 07:38 CEST Update https://www.mdpi.com/2218-0532/90/2/27/xml
article pdf uploaded. 26 April 2022 07:38 CEST Version of Record https://www.mdpi.com/2218-0532/90/2/27/pdf
article html file updated 26 April 2022 07:39 CEST Original file -
article html file updated 2 August 2022 20:47 CEST Update https://www.mdpi.com/2218-0532/90/2/27/html
Back to TopTop